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Understanding how compound penetration occurs
across the complex cell walls of Gram-negative bac-
teria is one of the greatest challenges in discovering
new drugs to treat the infections they cause. A com-
bination of next-generation transposon sequencing,
computational metadynamics simulations (CMDS),
and medicinal chemistry was used to define genetic
and structural elements involved in facilitated carba-
penem entry into Pseudomonas aeruginosa. Here we
show for the first time that these compounds are
taken up not only by the major outer membrane
channel OccD1 (also called OprD or PA0958) but
also by a closely related channel OccD3 (OpdP or
PA4501). Transport-mediating molecular interac-
tions predicted by CMDS for these channels were
first confirmed genetically, then used to guide the
design of carbapenem analogs with altered uptake
properties. These results bring us closer to the
rational design of channel transmissibility and may
ultimately lead to improved permeability of com-
pounds across bacterial outer membranes.
INTRODUCTION
Limited classes of antibiotics are available to treat Pseudo-
monas aeruginosa infections due to both intrinsic and acquired
resistance determinants, which include alterations in mem-
brane permeability, enhanced mechanisms of multi-drug efflux,
and acquisition of b-lactamases (Breidenstein et al., 2011).
Increasing antibiotic resistance in P. aeruginosa has led to major
concerns about the ability to successfully treat infections
caused by this important opportunistic pathogen (Fraimow
and Nahra, 2013; Pendleton et al., 2013). The carbapenems
are an important class of antibiotics that remain in use for
P. aeruginosa infections as they are less prone to degradation
by extended spectrum b-lactamases (Papp-Wallace et al.,
2011). Nevertheless, emerging carbapenem resistance is on
the rise; therefore the clinical utility of this class may also
dwindle in the near future.Chemistry & Biology 22,One of the biggest challenges in the design and development
of new drugs for the treatment of infections caused by
P. aeruginosa and other serious Gram-negative pathogens is
our relative ignorance of themolecular mechanisms driving com-
pound penetration across their outer membranes. One of the
most notable features of P. aeruginosa is its low outer membrane
permeability, which has been estimated to be only8% of other
bacterial membranes such as that of Escherichia coli (Hancock
and Woodruff, 1988). Unlike E. coli, which contain several large
and relatively nonspecific general porins, P. aeruginosa deploys
a variety of specialized outer membrane proteins to facilitate up-
take of nutrients needed for growth and survival (Hancock and
Brinkman, 2002), some of which are nonspecific channels,
such as OprF, and others that are substrate-specific trans-
porters with small pores, such as the Occ (outer membrane
carboxylate channel) family of transporters (Eren et al., 2012),
also known as the OprD family of channels (Tamber et al.,
2006). The 19 members in the latter family have been further
classified according to their preferential substrate selectivity;
although all family members prefer their substrates to contain
carboxylates, the OccD subfamily prefers cations (Liu et al.,
2012b) while the OccK subfamily takes up anions (Liu et al.,
2012a). This classification is based on data generated by fairly
cumbersome techniques such as liposome swelling assays (Haj-
jar et al., 2010), doubling time experiments (Tamber et al., 2006),
or radiolabeled substrate competition assays using membrane
vesicles containing individually overexpressed channels (Eren
et al., 2013, 2012). These challenging assays underscore an
additional need for this field of study, namely the development
of robust methods to more precisely assess compound uptake.
OccD1 (also called OprD or PA0958), the first member of the
Occ family to be characterized in depth, transports basic amino
acids (Figure 1, compounds 1 and 2) and, fortuitously, also facil-
itates entry of certain privileged carbapenems such as merope-
nem and imipenem (Figure 1, compounds 4 and 5). Indeed, the
first documented case of clinical resistance to this class of anti-
biotics in P. aeruginosa was found to be due to loss of this outer
membrane protein (Quinn et al., 1986), and it is now well estab-
lished that changes in OccD1 expression levels or sequence are
frequently associated with resistance to carbapenems in the
clinic (Quale et al., 2006), (Pirnay et al., 2002). A recent crystal
structure of OccD1 (PDB 3SY7) (Eren et al., 2012), (Biswas
et al., 2007) revealed an 18-strand b-barrel containing a small
channel lined on one side with a positively charged basic amino535–547, April 23, 2015 ª2015 Elsevier Ltd All rights reserved 535
Figure 1. Structures of Compounds Studied in this Work
1, Lysine; 2, arginine; 3, glycine-glutamate dipeptide; 4, meropenem; 5, imipenem; 6, doripenem; 7, meropenem analog 7; 8, imipenem analog 8.acid ladder. This is often called the constriction zone and is
widely accepted as the place where nutrients, ions, substrates,
and/or water pass through from the extracellular to the periplas-
mic space. The structure also revealed that the L7 insertion loop
(L7i) and the L3 loop within the protein, which abut the constric-
tion zone, may play a role in recognition of natural substrates
(Figure 2B) (Eren et al., 2012). The L7 loop forms a crown of back-
bone carbonyls that are separated approximately 120 relative to
the basic ladder. This feature creates an electrostatic recognition
framework that has a handedness ideally selective for the zwit-
terionic backbone amine and carboxylic acid of a free a-amino
acid. It is not immediately clear how OccD1 selects for the basic
side chains of the basic amino acids but it is reasonable to postu-
late that the electronegative recognition pocket of OccD1 may
play a role. The interactions that occur during translocation
through the constriction zone likely dictate the selectivity of the
channels and therefore the constriction zone is one of the most
important regions to study to better understand the molecular
recognition of this transporter. The diameter of the constriction
zone based on the crystallographic structure is 6 A˚ (between
the backbone carbonyl oxygens of Q304 and G128, the closest
pair of atoms in OccD1) and has a length of15 A˚ (A318 to H395
Ca-Ca distance). This small constriction zone coupled with elec-
trophysiology experiments led van den Berg and colleagues to
suggest that the structure is most likely in a closed state (Eren536 Chemistry & Biology 22, 535–547, April 23, 2015 ª2015 Elsevieret al., 2012). They subsequently tested a series of amino acid
substitutions to examine the role of specific residues predicted
to be involved in arginine uptake (Eren et al., 2012); a subset of
these are described in more detail below.
Given the likelihood that the structural features shared be-
tween the natural substrates of OccD1 and the carbapenems
serve as the molecular basis of their uptake, it is possible that
an improved understanding of how the recognition events
of the natural substrates occur could lead to the design of carba-
penems with enhanced uptake properties. In addition, it may
eventually be possible to design compounds that enter simulta-
neously throughmultiple channels. Thesemay have a decreased
risk for emergence of clinical resistance, since multiple channel
mutations would need to arise simultaneously for resistance
to occur. Ultimately, the ability to predict the uptake by
different channels may enable rational design of molecules
with enhanced uptake properties that may translate into more
efficacious antibiotics, which are so desperately needed.
To that end, we utilized a multidisciplinary approach to
begin addressing this challenging problem. In the first part of
this study, we characterized the uptake of meropenem by
P. aeruginosa on a global scale through the use of next-genera-
tion transposon junction sequencing (TNseq). This relatively new
platform allows for a snapshot of the contribution of all potential
outer membrane transporters to drug susceptibility during aLtd All rights reserved
Figure 2. Structural Overview of OccD1 and OccD3
(A) Schematic view showing the main substrate recognition elements in the
porins. Residues are labeled according to OccD1. From the extracellular
vestibule, the substrate first encounters residues of the basic ladder (blue
rectangles) and then enters the recognition pocket formed between the L7 and
L7i loops, where it interacts with D307 (D342), as well as the crown of car-
bonyls in the L7 loop (shown as red dots), while retaining interactions with the
basic ladder. From there, the substrate moves through the constriction zone
and into the periplasmic space.
(B and C) Cartoon representations of a substrate-specific recognition pocket
of OccD1 and OccD3, respectively. Images of OccD1 and OccD3 were
created using PyMOL and generated from PDB IDs 3SY7 and 3SYB,
respectively. (B) Side view of OccD1. (C) Side view of OccD3. The N-terminal
sequence PAPDNPSYAAEVQSIPSV of OccD3 was removed for clarity.
Dashed lines in green representmeasured distances of 8.3 A˚ and 15.7 A˚, which
correlate between Ca carbons of D295 and Q304 and Q329 and L340 for
OccD1 and OccD3, respectively. Arrows represent extracellular to periplasmic
space direction.
Chemistry & Biology 22,course of exposure and led to the identification of a second
OccD subfamily channel, OccD3 (OpdP or PA4501), which is
also capable of transporting carbapenems. The second compo-
nent of this study was inspired by recent efforts of Ceccarelli and
colleagues to build an understanding of channel function in
several species of Gram-negative bacteria using molecular
dynamic simulation (Hajjar et al., 2010; Kumar et al., 2010).
Recently, a similar study exploring translocation of arginine in
OccD1was published by Parkin and Khalid (2014). Our approach
used molecular metadynamics simulations, an atomistic simula-
tion technique that provides information about dynamical pro-
cesses at atomic resolution (Laio and Parrinello, 2002), to study
compound permeation through OccD1 and OccD3. Unlike tradi-
tional molecular dynamics methods, this allows the input of
small amounts of energy to a system to enhance the sampling
of physiologically interesting processes such as the transloca-
tion of small molecules through the OccD channels. Subtracting
the applied potential energy from the final simulation provides
a free energy profile for the process of interest. Using this
approach, in addition to confirming the role of OccD1 in merope-
nem uptake, we found that the lowest-energy path for transloca-
tion of imipenem mimics that of the natural substrate arginine in
OccD1. Interestingly, while meropenem does not appear to bind
deeply in the pocket in our simulations, it doesmake contact with
the backbone carbonyls of the L7 loop, which are part of the
recognition pocket. Furthermore, simulations on OccD3 predict
that imipenem andmeropenemmimic the pathway for its natural
dipeptide substrate glycine-glutamate (Gly-Glu) (Figure 1, com-
pound 3). The third aspect of our approach involved synthesizing
carbapenem analogs to chemically probe some of the required
features of permeation while seeking to maintain the inherent
acylation activity of the penicillin binding protein (PBP) enzymes
intact. We were able to generate an analog of meropenem for
which a simple substitution on the side chain resulted in dimin-
ished dependence on OccD1 for translocation, an important dis-
covery that could lead to better understanding of the design of
improved carbapenems addressing P. aeruginosa resistance.
Finally, using an imipenem analog, we demonstrated that alter-
ation of the basic side chain results in complete ablation of anti-
bacterial activity that is solely driven by permeation effects (as
enzymatic activity is actually improved over the parent struc-
ture). The deployment of such a multidisciplinary approach to
study the factors influencing drug permeation may represent a
breakthrough in the ability to design compounds with enhanced
outer membrane permeability, one of the greatest barriers in the
development of effective antibacterial drugs.
RESULTS
TNseq Confirms the Primary Role of OccD1 in
Meropenem Uptake
The channel OccD1 plays an important role in carbapenem up-
take in P. aeruginosa; its inactivation results in a 4- to 8-fold
decrease in meropenem susceptibility against laboratory strains
(Ko¨hler et al., 1999). We used TNseq to both confirm the primary
role of OccD1 in meropenem uptake and validate this method for
the determination of bacterial drug uptake mechanisms in gen-
eral. TNseq, or high throughput transposon junction sequencing
of saturated mutant libraries, is a recently developed platform535–547, April 23, 2015 ª2015 Elsevier Ltd All rights reserved 537
Table 1. Nonessential Geneswhose Inactivation ConfersMeropenemResistance inWild-Type versus occD1, also called oprD,Mutant
Strains of PAO1
LOCUS ID Gene Name Function Cellular Location Fold Enrichment
Wild-Type PAO1
PA0958 occD1/oprD small molecule transport outer membrane 71.6
PA3574 nalD regulator of efflux cytoplasm 60.01
PA1796 folD folate metabolism cytoplasm 59.86
PA0424 mexR regulator of efflux cytoplasm 41.15
PA5027 PA5027 hypothetical cytoplasm 40.04
PA3721 nalC regulator of efflux cytoplasm 37.94
PA3967 PA3967 hypothetical cytoplasm 25.25
PA2810 copS phosphorelay sensor kinase inner membrane 23.87
PA3831 pepA leucine aminopeptidase cytoplasm 21.19
PA0890 aotM arginine/ornithine transport inner membrane 21.07
PA5244 PA5244 hypothetical inner membrane 18.18
PA0161 PA0161 hypothetical unknown 17.7
PA2620 clpA ATP-binding protease cytoplasm 17.24
PA4076 PA4076 hypothetical inner membrane 17.1
PA5548 PA5548 probable transporter inner membrane 16.24
PA5333 PA5333 hypothetical inner membrane 15.96
PA0358 PA0358 hypothetical unknown 15.04
PA4218 ampP siderophore transport inner membrane 14.44
PA4000 rplA rare lipoprotein A homolog unknown 13.7
PA0571 PA0571 hypothetical unknown 12.84
PA3674 PA3674 hypothetical unknown 12.69
PA4522 ampD regulator of ampC cytoplasm 12.63
PA0467 PA0467 hypothetical unknown 11.86
PA4896 PA4896 probable sigma factor cytoplasm 11.15
PA5086 PA5086 hypothetical unknown 10.96
DoccD1 PAO1
PA3453 PA3453 hypothetical unknown 235.79
PA3902 PA3902 hypothetical periplasm 219.23
PA4181 PA4181 hypothetical unknown 211.05
PA5419 soxG sarcosine catabolism cytoplasm 206.47
PA3721 nalC regulator of transport regulator of efflux 202.4
PA4160 fepD enterobactin transporter inner membrane 192.29
PA1180 phoQ phosphorelay sensor kinase inner membrane 106.72
PA3574 nalD regulator of transport regulator of efflux 106.13
PA4522 ampD regulator of ampC cytoplasm 101.84
PA0424 mexR regulator of efflux cytoplasm 90.76
PA0468 PA0468 hypothetical unknown 60.81
PA0084 tssC1 type VI secretion system cytoplasm 59.57
PA4501 occD3/opdP Glyc-Glu dipeptide porin outer membrane 47.57
PA5443 uvrD DNA helicase (stress response) cytoplasm 46.45
PA4020 mpl UDP-N-acetylmuramate-alanine ligase cytoplasm 43.07
PA1121 yfiR hypothetical periplasm 42.06
PA3019 PA3019 ATP-binding subunit of ABC transporter cytoplasm 38.37
PA4058 PA4058 hypothetical unknown 37.16
PA4506 PA4506 ATP-binding subunit of ABC transporter cytoplasm 36.23
PA4726 cbrB phosphorelay response regulator cytoplasm 34.21
PA4799 PA4799 hypothetical unknown 26.91
(Continued on next page)
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Table 1. Continued
LOCUS ID Gene Name Function Cellular Location Fold Enrichment
PA4001 sltB1 soluble lytic transglycosylase B inner membrane 24.55
PA3831 pepA leucine aminopeptidase cytoplasm 23.76
PA4725 cbrA phosphorelay sensor kinase inner membrane 22.66
PA0545 PA0545 hypothetical inner membrane 20.55
The locus ID, gene name and function, and cellular location of the top 15 geneswhose inactivation resulted in the highest levels of enrichment after drug
treatment are shown.(van Opijnen et al., 2014) that is currently being used to evaluate
fitness and/or virulence determinants in a wide variety of
bacterial pathogens (see for example Subashchandrabose
et al., 2013; Palace et al., 2014; Wang et al., 2014), including
P. aeruginosa (Skurnik et al., 2013). A pool of approximately
50,000 unique transposon insertion mutants in PA01 was
exposed to meropenem at 13minimum inhibitory concentration
(MIC) in richmedia for 6 hr, at which point the surviving cells were
collected for TNseq analysis. As expected, a number of mutants
with previously described roles in carbapenem resistance, such
as negative regulators of efflux (mexR, nalD, and nalC) or b-lac-
tamase activity (ampD) (Moya et al., 2009; Sobel et al., 2005),
were found to be highly enriched in the meropenem-treated
sample (Table 1, upper panel). Mutants with transposon inser-
tions in occD1were also found to be greatly enriched, confirming
the previously established role of OccD1 in the uptake of this
compound. No other genes encoding outer membrane proteins
showed this degree of enrichment (Table S1). These data sug-
gest that that no additional channels contribute significantly
to meropenem uptake by P. aeruginosa in rich media when
OccD1 is present. Representative single transposon mutants
from those found to be most highly enriched by this selection
were tested individually for relative sensitivity to meropenem
by disk diffusion on both rich and minimal media (data not
shown); all those tested were found to be less susceptible than
the wild-type parent PAO1, confirming our TNseq results and
validating the platform.
TNseq Analysis Reveals an Additional Mechanism of
Meropenem Uptake
Although an occD1 deletion mutation in PAO1 results in an
elevated meropenem MIC (Ko¨hler et al., 1999), this concentra-
tion is at or near the CLSI breakpoint of 2 mg/ml (Hombach
et al., 2012). The fact that meropenem still shows some activity
in an occD1 deletion mutant suggests that alternative mecha-
nisms of meropenem uptake exist in the absence of functional
OccD1. In order to test this hypothesis, we constructed a trans-
posonmutant library (also containing50,000 unique insertions)
in a PAO1 DoccD1 background and subjected this second
pooled library to meropenem stress in the same manner as the
wild-type parent. Again, mutations in genes involved in repres-
sion of efflux and b-lactamaseswere found to be highly enriched,
as expected (Table 1, lower panel). Of particular note was the
significant enrichment of TN mutations in occD3 (PA4501; Table
S1). OccD3 is another member of the OccD subfamily of chan-
nels in P. aeruginosa that bears the highest degree (50%) of ho-
mology to OccD1 (Tamber and Hancock, 2006). Although this
transporter preferentially allows uptake of glycine-glutamate di-Chemistry & Biology 22,peptides (Tamber et al., 2006), it has been shown that it, like
OccD1, is also capable of transporting arginine and that its
expression is specifically upregulated upon arginine exposure
(Tamber and Hancock, 2006). This redundancy in function be-
tween OccD1 and OccD3 combined with our TNseq results
strongly suggested that OccD3 may constitute a secondary car-
bapenem uptake mechanism.
The Loss of occD3 Causes a Significant Increase in
Carbapenem MIC when Combined with Loss of occD1
To confirm the relative contribution of OccD1 and OccD3 in car-
bapenemuptake as suggested by the TNseq results, deletions of
both genes, alone and in combination, were generated in a PAO1
background, and MICs of these mutant strains were determined
in rich (MHBII) and minimal (M9S) media. As summarized in
Table 2, inactivation of occD1 resulted in a 4-fold increase in
MIC for the carbapenems (meropenem, imipenem, and doripe-
nem) in rich medium, with no changes in susceptibility observed
for control compounds (ceftazidime, tobramycin, and ofloxacin).
Inactivation of occD3 alone did not result in a significant change
in susceptibility to any compound tested in either rich or minimal
medium. Although theMIC of the carbapenems was significantly
lower in minimal medium for all the strains tested, only a 2-fold
difference was observed for the wild-type versus the occD1
mutant under these conditions. However, a DoccD1DoccD3
double mutant led to a remarkable decrease in susceptibility
to the carbapenems (16- to 64-fold) but not control compounds.
A decrease in susceptibility, albeit less striking, was also
observed when the same comparison was made in rich me-
dium (4- to 16-fold). Expression of OccD1 or OccD3 in the
DoccD1DoccD3 double mutant in trans restored susceptibility
to carbapenems and led to lower MICs than observed for the
wild-type parent, whereas no effect was seen for control com-
pounds or when a member of the OccK subfamily (OccK7, also
called OpdD) was overexpressed. These results clearly demon-
strate that both OccD1 and OccD3 specifically facilitate the
transport of carbapenems and suggest that both channels may
do so concomitantly under nutrient limiting conditions. Results
for control compounds confirmed that the effect of channel over-
expression was channel specific, and did not cause a general in-
crease in the porosity of the outer membrane. To determine if
other closely related OccD subfamily members also play a role
in carbapenem uptake, a strain was generated with deletions
in the genes encoding the five OccD channels with the greatest
level of expression based on RNA seq analysis of PAO1
in minimal medium (data not shown), namely DoccD1, DoccD2
(DopdC), DoccD3, DoccD4 (DopdT), and DoccD7 (DopdB).
No difference in susceptibility was observed between the535–547, April 23, 2015 ª2015 Elsevier Ltd All rights reserved 539
Table 2. Genetic Confirmation that Carbapenem Transport Is Facilitated by OccD1 and OccD3
MER Fold Changea IMP
Fold
Changea DOR
Fold
Changea Compound 7
Fold
Changea CAZ TO OX
Rich medium (MHBII)
PAO1 0.5 – 1 – 1 – 4 – 2 0.5 0.5
DoccD1 2 [43 8 [83 2 [23 8 [23 2 0.5 0.5
DoccD3 1 [23 1 NC 1 NC 4 NC 2 1 0.5
DoccD1 DoccD3 4 [83 16 [163 4 [43 8 [23 2 0.5 0.5
DoccD1-occD4, DoccD7 4 [83 16 [163 4 [43 8 [23 2 0.5 1
DoccD1 DoccD3/pPSV35 (empty) 4 – 16 – 2 – 4 – 1 0.5 0.5
DoccD1 DoccD3/pPSV35_occD1 0.125 Y323 0.25 Y643 0.125 Y163 2 Y23 1 1 0.5
DoccD1 DoccD3/pPSV35_occD3 0.25 Y163 0.5 Y323 0.25 Y83 2 Y23 1 1 0.5
DoccD1 DoccD3/pPSV35_occK7 4 NC 16 NC 2 NC 4 NC 1 1 0.5
Minimal media (M9S)
PAO1 0.031 – 0.25 – 0.063 – 0.25 – 1 2 0.5
DoccD1 0.063 [23 0.5 [23 0.125 [23 0.5 [23 2 2 0.5
DoccD3 0.031 NC 0.25 NC 0.063 NC 0.25 NC 2 1 0.5
DoccD1 DoccD3 2 [643 4 [163 1 [163 0.5 [23 2 1 0.5
DoccD1-occD4, DoccD7 2 [643 4 [163 1 [163 0.5 [23 1 1 0.5
The activity (MIC, in mg/ml) of each test compound against PAO1 wild-type versus channel-deficient strains in the absence and presence of comple-
menting plasmids in rich (MHBII) versus minimal (M9S) medium is shown. Where indicated, fold change is relative to the activity of the PAO1 parent
strain. MER, meropenem; IMP, imipenem; DOR, doripenem; CAZ, ceftazidime; TO, tobramycin; OX, ofloxacin. All MIC tests were performed at least in
triplicate.
aCompared with activity against parent PAO1.five-channel mutant and the DoccD1DoccD3 double mutant in
either medium tested (Table 2), suggesting that only OccD1
and OccD3 are major contributors to carbapenem transport un-
der these conditions.
Characterization of Transporters in a Cell-Based
Heterologous Expression Assay
P. aeruginosa contains 19 outer membrane channels in theOccD
and OccK subfamilies that are highly similar to one another and
whose expression is controlled by complex regulatory path-
ways. This complexity is further confounded by numerous efflux
systems, which limits our ability to analyze the relative contribu-
tion of individual channels in carbapenem uptake in a
P. aeruginosa background beyond the broad conclusions
made above. Therefore, to further examine the function of
OccD1 and OccD3 in carbapenem uptake, we developed a
cell-based assay that relies on the heterologous expression of
these channels in E. coli Omp8 (Prilipov et al., 1998). Genes en-
coding all the major endogenous E. coli porins (namely lamB,
ompF, ompA, and ompC) have been deleted in this strain. As
shown in Table 3, expression of OccD1 or OccD3 in Omp8 in
trans caused a 32-fold and 16-fold decrease in the MIC of mer-
openem, respectively, whereas expression of another member
of the OccD subfamily, OccD2 (or OpdC [PA0162]), or of an
OccK subfamily channel, OccK7 (or OpdD [PA1025]), had little
to no effect. Similar MIC patterns were also observed for imipe-
nem and doripenem against these strains, whereas the activity of
control compounds (ceftazidime, tobramycin, and ofloxacin)
were unaffected (Table 3).
The ability of carbapenems to compete with the natural sub-
strates of the OccD1 and OccD3 channels was also explored.540 Chemistry & Biology 22, 535–547, April 23, 2015 ª2015 ElsevierWe found that 50 mM concentrations of arginine and lysine,
but not glycine-glutamate (Gly-Glu), reduced the activity of mer-
openem in E. coliOmp8 overexpressing OccD1 but had no effect
on OccD3-overexpressing strains (Table 4). However, no signif-
icant effect was observed upon competition with imipenem un-
der any of the conditions tested. This apparent contradiction
with the MICs shown in Table 3 indicates possible differences
in native substrate and carbapenem uptake or ability to compete
for binding, as will be explored later in the article by molecular
dynamics modeling. These results are in partial agreement with
recent results obtained by Eren et al. (2012), who tested the abil-
ity of purified channel-overexpressing membrane vesicles to
take up radiolabeled natural substrates in the presence or
absence of a variety of antibiotics, and showed that both mero-
penem and imipenem could compete with arginine uptake by
OccD1 as previously described (Trias and Nikaido, 1990; Huang
and Hancock, 1993) but neither molecule could compete with
arginine uptake by OccD3. In contrast to our results, these au-
thors interpreted their results to mean that OccD3 is incapable
of carbapenem transport. It is possible that the results of these
studies may differ depending on how the measurements are
made to evaluate competition; Eren et al. (2012) measured the
effect of excess antibiotic on substrate uptake, whereas in this
report the opposite evaluation, i.e. the effect of excess substrate
on antibiotic uptake, was made. Alternatively, this discrepancy
could be explained by the possibility that sufficient differences
exist between the transient binding modes of natural substrates
versus carbapenems in OccD3, so that these molecules do not
in fact compete directly with each other for transport. We
subsequently used computational metadynamics simulations
to compare the interactions among the substrates andLtd All rights reserved
Table 3. Whole-Cell Compound Uptake Assay Confirms that OccD1 and OccD3 Both Facilitate Carbapenem Transport, which Is
Compromised in a Rationally Designed Meropenem Analog
Omp8 E. coli Bearing MER Fold Change IMP Fold Change DOR Fold Change Compound 7 Fold Change CAZ OX TO
pB22 (empty) 8 – 4 – 4 – 4 – 1 1 0.016
pB22_OccD1 0.25 Y323 0.5 Y83 0.25 Y163 0.5 Y83 1 0.5 0.016
pB22_OccD3 0.5 Y163 0.5 Y83 0.5 Y83 0.5 Y83 0.5 0.5 0.016
pB22_OccK7 8 NC 4 NC 4 NC 4 NC 0.5 0.5 0.016
pB22_OccD2 4 Y23 2 Y23 2 Y23 2 Y23 0.5 1 0.016
The activity (MIC, in mg/ml) of each test compound against an E. coli porin-deficient strain, omp8, containing overexpression plasmids as indicated, is
shown.Where indicated, fold change is relative to the activity of the omp8 parent strain with an empty vector. MER,meropenem; IMP, imipenem; DOR,
doripenem; CAZ, ceftazidime; TO, tobramycin; OX, ofloxacin. All MIC tests were performed at least in triplicate.carbapenems with OccD1 and OccD3, both to address this hy-
pothesis and to further define the structural elements that may
be involved in carbapenem transport.
Use of Computational Metadynamics Simulations to
Define Structural Elements of Carbapenem Transport
Computational metadynamics simulations were employed to
better understand how the natural substrates or antibacterial
compounds behave in the constriction zone of OccD1 and
OccD3.
Two collective variableswere selected: the position of the sub-
strate along the long axis of the channel, or its Z coordinate; and
a second variable designed to improve sampling within the
recognition pocket (Figure S1). The metadynamics biased po-
tentials selected enable enhanced sampling through the chan-
nels and result in a two-dimensional projection of the free energy
surface. Obtaining accurate free energy profiles/barriers for
complex biological processes is notoriously difficult, due to the
huge amounts of computer time required to adequately sample
all relevant degrees of freedom in a suitablemodel system. Great
strides have beenmade using specialized hardware (Shaw et al.,
2010) and GPU-enabled molecular dynamics codes (Lawrenz
et al., 2015) yet in practice these methods are still too costly
for routine application, for example, for rank ordering the
permeability of a membrane channel to a series of ligands. Meta-
dynamics is one of a number of so-called enhanced sampling
techniques developed to reduce the amount of simulation time
(and therefore computer time) required to model such pro-
cesses. Metadynamics works by injecting small amounts of en-
ergy into the model system of interest in order to discourage
components of the system from repeatedly adopting configura-
tions that have been previously sampled in a simulation; in that
way, the method achieves the desired effect of sampling a larger
fraction of configurational space in the same overall simulation
time. The fact that metadynamics perturbs the system by adding
energy can result in sampling nonphysical configurations. For
simple systems, this can be avoided by careful choice of the
amount of, and frequencywith which, energy is added to the sys-
tem. For large systems with many degrees of freedom, however,
it is much more difficult to choose values for these parameters
that do not produce nonphysical configurations yet still provide
the benefit of enhanced sampling.We found that, inmetadynam-
ics simulations of porin/ligand complexes, trajectories that
involved nonphysical configurations corresponded to unrealisti-
cally high translocation free energies. We therefore adopted theChemistry & Biology 22,strategy of running numerous (100) simulations for each porin/
ligand complex, monitoring changes in the translocation barrier
as a sort of convergence criterion and utilizing only the lowest-
energy trajectories when comparing the energetics of different
complexes. Furthermore, we found that constraining the porins
in the open conformation reduced the frequency of high-energy
configurations, gavemore rapid convergence, and increased the
confidence with which comparisons of the free energy barrier
due to the constriction zone could be made. Due to the use of
constraints, these calculations probably cannot provide mean-
ingful structural insights into flexible regions of the protein, for
example interactions with the loops in the extracellular vestibule,
which are additionally confounded by the need to accurately
model interactions with lipopolysaccharide molecules in the
outer leaflet and which have so far eluded simulation. However,
we show that this approach is fit for purpose as a medium-
throughput virtual screening platform for the structure-based
design of compounds with enhanced porin permeation
characteristics.
Theminimum free energy profile thus obtained for each system
is shown in FigureS2. In order to simplify comparison among sys-
tems, the resulting free energy surface obtained from each simu-
lation was normalized by setting to zero theminimum free energy
observed for the system configuration with the substrate in the
vestibule on the extracellular side of the constriction zone
(centered around a Z coordinate value of 10 A˚). The superim-
posedprofiles forOccD1 are shown in Figure S3A.On this profile,
the origin (Z coordinate value of 0) corresponds to the center of
the channel as defined in the Proteins in Membranes database
(Lomize et al., 2006), with the positive axis oriented toward the
extracellular space. The substrate recognition pocket is located
beyond the center of the channel toward the periplasmic side
and corresponds to a Z coordinate value of5 A˚. In this pocket,
substrates of OccD1 appear to make favorable interactions with
Asp 307 and Arg 391 (see Figure 3; Discussion).
The native substrate, arginine, experiences the lowest free en-
ergy barrier on translocation through OccD1, and is stabilized in
the recognition pocket by 3 kcal/mol. Imipenem experiences a
slightly larger barrier of 6 kcal, but is similarly stabilized in the
recognition pocket by 4 kcal relative to the vestibular configu-
ration. In the simulations, imipenem closely mimics the electro-
static signature of arginine and makes similar interactions with
Asp 307 and Arg 391 (Figure 3B) in the recognition pocket.
In contrast, meropenem is not significantly stabilized by interac-
tions in the recognition pocket relative to the vestibule, although535–547, April 23, 2015 ª2015 Elsevier Ltd All rights reserved 541
Table 4. Defining Key Residues in Carbapenem Transport Using the Whole-Cell Compound Uptake Assay in the Absence or Presence
of the Natural Substrates of OccD1 and OccD3
Overexpression Construct
Meropenem Imipenem
NA Arginine Lysine Gly-Glu NA Arginine Lysine Gly-Glu
pB22 (empty) 8 8 8 8 4 4 4 4
WT OccD1 0.25 4 4 0.25 0.5 1 1 1
Y176A 2 8 8 2 1 2 2 1
Y282A 0.125 2 2 0.125 0.5 1 1 0.5
Y282R 8 8 4 4 4 2 2 2
D295A 0.25 2 2 0.25 0.5 0.5 1 1
D295H 0.25 2 2 0.25 0.5 0.5 1 1
Y282R, D307H 4 4 4 4 2 1 2 2
D307A 0.25 0.25 0.25 0.125 0.5 0.5 0.5 0.5
D307H 4 4 4 4 2 1 2 2
R389A 1 4 4 1 1 1 2 1
R391A 1 4 4 0.5 1 1 2 1
R410A 2 4 4 2 1 1 2 1
WT OccD3 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5
Y326A 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5
Y326R 0.5 0.5 0.5 0.5 0.5 0.5 0.5 1
D342A 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5
D342H 1 1 1 1 1 1 1 1
The activity (MIC, in mg/ml) of either meropenem or imipenem against an E. coli porin-deficient strain, omp8, overexpressing either wild-type or mutant
OccD1, in the presence of 50 mM arginine, lysine or Gly-Glu, is shown. NA, no amino acid added. All MIC tests were performed at least in triplicate.it exhibits a similar barrier to imipenem. In the Y282R/D307H
double mutant, which introduces unfavorable interactions in
the recognition pocket, the barrier to translocation of imipenem
rises to 12 kcal/mol and the relative stabilization in the recog-
nition pocket is lost. The barrier for meropenem is indeterminate
asmeropenemwas not observed to enter the recognition pocket
or even sample configurations beyond the center of the channel
in any of the simulations run with this double mutant. Qualita-
tively, the energy barriers and relative stabilization in the recog-
nition pocket of imipenem and meropenem in wild-type and
mutant OccD1 are consistent with the observed trends in cellular
activity.
Amino Acid Substitutions Reveal Important Differences
in Substrate versus Carbapenem Transport
To further characterize the contribution of key channel residues
shown to interact with natural substrates and their effect on
the ability to transport carbapenems in OccD1 and OccD3, we
generated a number of point mutants based both on the molec-
ular modeling results described above and on previous work by
the van den Berg laboratory. These researchers evaluated the ef-
fect of a number of amino acid substitutions at predicted natural
substrate transient binding residues of OccD1 and analyzed their
ability to transport arginine (Eren et al., 2013). They found that re-
placing conserved residues Arg389, Arg391, and Arg410 within
the basic ladder and Asp307 within the recognition pocket (Fig-
ure 2) with alanine resulted in the biggest effect on arginine up-
take. Reversing the charge of the recognition pocket residues
by converting Tyr176, Tyr282, or Asp307 to arginine or histidine
had little effect when the mutants were tested individually, how-542 Chemistry & Biology 22, 535–547, April 23, 2015 ª2015 Elsevierever, the double mutant Tyr282Arg/Asp307His and the triple
mutant Tyr176Arg/Tyr282Arg/Asp307His both showed major
deficiencies in arginine transport (Eren et al., 2013). Accordingly,
we generated several of these mutations and tested them in our
cell-based compound uptake assay with and without competi-
tion by excess natural substrate (Table 4). Within the recognition
pocket, we found that changing Tyr176 to alanine resulted in an
MIC shift from 0.25 to 2 mg/ml for meropenem and 0.5 to 1 mg/ml
for imipenem, i.e. it reduced but did not abolish the level of car-
bapenem uptake, and addition of Arg or Lys (but not Gly-Glu) to
the culture medium rendered the channel inactive for merope-
nem, suggesting competition still occurred in the presence of
this mutation. In contrast, a Tyr282Ala mutant had no effect on
MICs, i.e. showed wild-type levels of carbapenem uptake and
active competition with Arg or Lys but a Tyr282Arg mutant had
the same MIC as empty vector, suggesting it is incapable of
transporting carbapenems. Although mutation of Asp307 to Ala
reduced arginine uptake according to Eren et al. (2012), we
found this change had no effect on carbapenem uptake by
OccD1. Of particular interest is the fact that this mutation ap-
peared to abrogate competition with natural substrates as their
addition had no effect on carbapenem susceptibility. In contrast,
changing Asp307 to a histidine had a significant effect on carba-
penem transport, whereas this mutation had no effect on argi-
nine transport according to Eren et al. (2012). Not surprisingly,
the double mutant Tyr292Arg/Asp307His is equally ineffective
in carbapenem transport as either mutant tested alone (Table 4).
We then tested several mutations within the basic ladder;
Arg389Ala, Arg391Ala, and Arg410Ala mutants all showed a
reduction but not complete loss of carbapenem transport (withLtd All rights reserved
Figure 3. Modeled Interactions with the Recognition Pocket
All channels were aligned using the protein structure alignment tool in Schrodinger.
(A) Arginine with OccD1.
(B) Imipenem with OccD1.
(C) Meropenem with OccD1.
(D) Glycine-glutamate with OccD3.
(E) Imipenem with OccD3.
(F) Meropenem with OccD3.
Arrows represent the extracellular to periplasmic space direction.2- to 4-fold shifts in MIC compared with wild-type OccD1) and all
showed competition with Arg or Lys. Overall, these results sug-
gest that the mode of transient binding of carbapenems to
OccD1, although similar, is not identical to the transient binding
of natural substrates arginine and lysine. Similarly, we evaluated
the effect of altering two key residues within the predicted recog-
nition pocket of OccD3 Tyr326 and Asp342 (Figure 2C). Chang-
ing either of these to either Ala/Arg or Ala/His, respectively, had
no effect on carbapenemMICs compared with wild-type OccD3,
suggesting that neither affected its recognition or transient bind-
ing of these molecules. Addition of excess Gly-Glu also had no
effect. These results support the conclusion generated by
modeling and metadynamics simulations described above,
namely that themode of carbapenem transport by OccD3 differs
in several important ways from that of OccD1.Chemistry & Biology 22,Carbapenem Analogs with Altered Uptake Properties
In order to facilitate the rational design of carbapenems with
altered uptake properties, we focused our attention on the
side-chain derivatives of these carbapenems recognizing that
several features of the core molecule are required for PBP bind-
ing (e.g. the activating group carboxylate, hydroxylethyl group).
Compound 7 (Figure 1) was designed to explore the importance
of the dimethyl amide moiety in meropenem and explore the ef-
fect of adding an additional negative charge to the molecule.
Interestingly, while compound 7 does lose some cellular activity,
its dependence on OccD1 as a major route of permeation ap-
pears significantly diminished with MICs of 4–8 mg/ml across
wild-type and channel-deficient strains (Table 2) and much less
activity in the OccD1 overexpressing E. coli strain compared
with meropenem (Table 3). Similarly, compound 8 (Figure 1)535–547, April 23, 2015 ª2015 Elsevier Ltd All rights reserved 543
(Eguchi et al., 2007; Kanazawa et al., 1999) was synthesized as
an analog, which could abolish the favorable interactions that
imipenem makes with Asp307 in the recognition pocket and
thus remove specificity for OccD1 and potentially enable
enhanced permeation through OccD3. Notably, the barrier to
translocation in the simulations for compound 8 rose beyond
20 kcal/mol (Figure S3B), further supporting the importance of
favorable interactions with Asp 307 in the recognition pocket.
This resulted in complete lack of cellular activity of compound
8 while the potency on the PBP3 target actually improved
5-fold (Table S3).
In OccD3, there is effectively no barrier to translocation for the
native substrate, Gly-Glu (see Figure S3B). The privileged carba-
penems imipenem andmeropenem also exhibit modest barriers,
consistent with a role for OccD3 in the uptake of these antibi-
otics. Neither drug binds deeply in the Gly-Glu recognition
pocket, mostly likely due to its being in a more open state
(Figure 2C). This suggests that further optimization of these
compounds may be possible in order to increase permeability
and reduce susceptibility to OccD1-mediated carbapenem
resistance.
DISCUSSION
The success rate in the identification of novel antibacterial
agents to treat Gram-negative infections is insufficient; indeed,
an agent acting via a novel mechanism of action has not been
discovered in nearly half a century. In order to address this med-
ical need, novel approaches to this very challenging problem
must be undertaken immediately. Typically, drug discovery pro-
grams aimed at the design of novel Gram-negative agents use
cell-based susceptibility assays on wild-type or permeabilized
strains. While this type of assay can provide meaningful informa-
tion for chemical series that exhibit whole-cell killing activities, it
is a rather blunt toolset when the goal is to design better perme-
ation into a series that inhibits an essential target but suffers from
poor permeability. The work described here illustrates our early
attempts to build a multidisciplinary approach to this challenge
by incorporating: (1) methods to identify channels involved in
permeation for novel compounds, (2) genetically altered cell-
based systems to probe the relevance of these channels, (3) mo-
lecular simulation to identify key residues involved in recognition,
which can be tested in the genetically altered cell systems, and,
ultimately, (4) application of the structural information obtained
from these methods in the design of analogs to test and confirm
these hypotheses. This new toolkit should provide us with infor-
mation about cell permeation in a much more focused manner
than has been demonstrated previously and thus eventually
allow the design of novel antibacterials with much more resolu-
tion than is provided by the traditional blunt tools that have his-
torically driven drug discovery in this area.
While the results described herein are preliminary, their signif-
icance illustrates the great promise of this approach. Using the
TNseq platform, we have discovered a second mode of perme-
ation for meropenem in OccD3. Our modeling work on this
channel was based on its solved crystal structure and its further
exploration will be communicated in due course. Our work on
OccD1 led to the design of compound 7, a meropenem analog
that appears to permeate with much less dependence on544 Chemistry & Biology 22, 535–547, April 23, 2015 ª2015 ElsevierOccD1 yet still exhibits antibacterial activity. Another interesting
result highlighted in this work is our finding that N-acetyl thiena-
mycin (compound 8), an imipenem analog devoid of the positive
charge provided by the amidine moiety is inactive in cells due to
issues of permeability, as its acylation rate of PBP3 is actually
enhanced compared with that of imipenem. Ourmodeling efforts
have identified further key residues that are involved in the struc-
tural recognition of OccD1 and further efforts are underway to
use these data to design analogs that take advantage of these
interactions. This finding is in agreement with work from Lou
et al. (2011) who found that subtle changes in the constriction
zone of E. coli OmpC appears to affect antibiotic uptake while
maintaining suitable nutrient uptake.
While we are not yet close to solving this important problem,
these efforts may pave the way for a new approach to under-
standing Gram-negative permeation, which we hope will ulti-
mately lead to novel antibacterials in this much needed area.
SIGNIFICANCE
One of the biggest challenges in the design and develop-
ment of new drugs for the treatment of infections caused
by P. aeruginosa and other serious Gram-negative patho-
gens is our relative ignorance of the molecular mechanisms
driving compound penetration across their outer mem-
branes. Definition of these mechanisms is considered to
be essential for significant advances in the ability to ratio-
nally design antimicrobial compounds, yet they still remain
poorly understood. This challenging problem was assessed
through the implementation of a multidisciplinary approach,
namely genetics, molecular dynamics simulations, and me-
dicinal chemistry to first identify uptake determinants,
followed by analysis of uptake on an atomic scale, and ulti-
mately, the rational design and synthesis of novel antibiotic
analogs with altered uptake properties. Saturated trans-
poson libraries were subjected to treatment with merope-
nem and analyzed by TNseq. Results not only confirmed
the well-established role of OccD1/OprD in meropenem up-
take but also identified a previously unknown second mode
of transport via the channel OccD3/OpdP. Carbapenem pas-
sage through these channels was confirmed with a novel
cell-based assay, and further defined at the atomic level us-
ing computational metadynamics simulations. These results
were then used to rationally design carbapenem analogs,
which demonstrated the predicted alteration in channel
transmissibility. This report demonstrates the potential for
the rational design of bacterial compound uptake. These
findings also lay the groundwork for the deployment of a
platform that may be applicable for investigating the uptake
of potentially any class of antibacterial compounds.
EXPERIMENTAL PROCEDURES
Growth of Bacterial Strains
Strains of P. aeruginosawere grown in Luria-Bertani agar (BD cat. no. 244510),
MHBII (BD cat. no. 297311), or M9 minimal medium (BD cat. no. 248510) con-
taining 30 mM sodium succinate as a carbon source (M9S). Gentamicin was
used at 30 mg/ml where appropriate. For plasmid maintenance during mutant
construction in P. aeruginosa, the medium was supplemented with 200 mg/ml
of carbenicillin and 100 mg/ml of tetracycline. Strains of E. coli were grown inLtd All rights reserved
LB orM9minimal medium containing 0.2% glucose as a carbon source (M9G).
Ampicillin or gentamicin were used at 100 mg/ml or 12 mg/ml, respectively,
where appropriate.
Construction of Mutant and Overexpression Strains in PAO1 and
E. coli Omp8
PCR products of the 533-bp upstream and 544-bp downstream regions of the
occD1/oprD (PA4501) open reading frame (ORF) in PA01 were fused by splice
overlap extension PCR to flank a third PCR product consisting of a gentamicin
resistance gene (aacC1) along with the Flp recombinase target (FRT) sites on
either side of the gene, resulting in a final fragment of 2073 bp which was
cloned into TOPO vector (TOPO TA Cloning Kit K4500-01 from Invitrogen).
The TOPO cloning reaction was transformed into E. coli TOP10 cells
(C4040-10, Invitrogen). Positive clones, which were selected on LB agar con-
taining 30 mg/ml, were screened by colony PCR. The desired sequence in the
positive clone, pAN134, was confirmed by Sanger sequencing. Plasmid
pAN134, which behaves as a suicide vector in P. aeruginosa, was then electro-
porated into PA01 containing pAN131 (a derivative of pUCP18 that contains
lRed genes (abd) whose expression is controlled by the arabinose-inducible
pBAD promoter as well as the counter-selectable marker sacB) as described
in Lesic and Rahme (2008). Positive clones (where the ORF of occD1 was re-
placed by aacC1) were selected on LB supplemented with 15 mg/ml genta-
micin, then cured of pAN131 by counterselection of colonies that survived
overnight growth on LB agar containing10% sucrose. The insertion of the
aacC1 gene in the ORF of occD1 was confirmed by PCR followed by Sanger
sequencing. This gentamicin resistance marker was excised by electroporat-
ing a pFLP3 plasmid (Choi et al., 2005) that expresses the Flp recombinase,
which induces recombination at the engineered FRT sites, resulting in an un-
marked deletion of occD1. Finally, the pFLP3 plasmid was cured from DoprD
strain by sucrose selection as described above. The clean occD1 deletion was
confirmed by next-generation sequencing (Illumina MiSeq) of total genomic
DNA purified from the strain. PAO1 DoccD3/opdP and the five-channel
knockout strain (DoprD/occD1, DopdC/occD2 DOpdP/occD3, DopdT/
occD4DopdB/occD7) were constructed byMicrobiotix. The unmarked double
deletion mutant PAO1 DoccD1DoccD3 was engineered following the same
protocol used for constructing DoccD1 using DoccD3 as the parent strain.
Forconstructionof channel overexpression vectors forP.aeruginosa, channel
genes were amplified with iProof High-Fidelity DNA polymerase with primers
containing SacI (50 end) or BamHI (30 end) restriction sites (Bio-Rad). Fragments
were ligated to SacI/BamHI (New England Biolabs) digested E. coli/P. aerugi-
nosa shuttle vector pPSV35 (Rietsch et al., 2005). Ligations were used to trans-
form E. coli Top 10 strain (Life Technologies) with selection on gentamycin.
Clones were selected and the presence of the channel insert was confirmed
by sequencing and restriction analysis. Plasmid was recovered and used to
transform PAO1 strains. For construction of pseudomonal channel overexpres-
sion vectors in E. coli, plasmid pB22, which contains an N-terminal E. coli outer
membraneproteinsignal sequence (Erenetal., 2012),wasamplifiedwith inverse
primers, with the upstream reverse primer containing a 50 phosphate and the 30
forward primer including the pB22 XbaI site. Channel geneswere amplified with
upstreamprimers containinga 50 phosphate and30 primers at the XbaI site. PCR
productswere digested with XbaI, ligated (Express Link; Life Technologies) and
used to transform E. coli Omp8. Inverse PCR was used to create amino acid
mutations within channel genes. Mutations were made in overlapping primers
oriented in opposite directions to amplify the entire pB22 plasmid containing
wild-type OccD1 or OccD3. DpnI was used for the digestion of parental DNA
from the PCR reaction, followed by transformation of E. coli Omp8 cells (Table
S4). All primer sequences are available upon request.
MIC Determination in P. aeruginosa
For MIC determination in PAO1 strains, overnight stationary cultures were
diluted 1:10,000 and used to inoculate MIC plates (Corning 3799) containing
test antibiotics. Final concentrations of isopropyl b-D-1-thiogalactopyranoside
(Invitrogen) at 100 mM and gentamicin at 30 mg/ml were used where appro-
priate. All strains were grown in MHBII or M9S.
Construction of Transposon Mutant Libraries in PAO1
Plasmid pAZ200, which contains a TN5 derivative with a tetracycline resis-
tance cassette between the transposon mosaic ends and a transposase andChemistry & Biology 22,genes necessary for conjugal transfer outside of the mosaic ends, was used
to transform E. coli mating strain SM10. Donor E. coli and recipient
P. aeruginosa strains were grown in 20-ml cultures overnight in LB.
P. aeruginosa cultures were heat shocked for 1 hr at 42C. Donor and recipient
cultures were mixed in a 1:1 ratio and centrifuged for 10 min at 5,0003 g. Cell
pellets were resuspended in 250 ml of LB containing 1mMMgCl2, spotted onto
47-mm Nuclepore polycarbonate track-etch membranes (Whatman), and
incubated at 37C for 5 hr. Filters were resuspended in 5ml of LB and the entire
suspension was spread over 150-mm diameter petri plates containing LB with
tetracycline at 60 mg/ml and chloramphenicol at 10 mg/ml to counterselect
against E. coli. After 2 days of incubation at 37C, the resulting resistant col-
onies were scraped and pooled in LB, and aliquots were frozen for storage.
Antibiotic Treatment of Pooled TN Libraries
Approximately 53 106 cfu from pooled TN mutant libraries were used to inoc-
ulate 10 ml of LB containing meropenem at the MIC. For TNseq input and
output samples, 100-ml aliquots were removed from cultures before and after
drug treatment, resuspended in fresh LB, and spread over multiple 150-mm
petri plates. To prevent overgrowth and overrepresentation of fast-growing
mutants, plates were incubated for 14 hr at 30C. Colonies were scraped,
pooled, pelleted, and used for preparation of TNseq genomic libraries.
Preparation of TNseq Genomic Libraries
TNseq libraries were prepared based on the protocol from the Camilli labora-
tory (van Opijnen et al., 2014). Please see the Supplemental Information for a
detailed explanation of the method employed in the generation, sequencing,
and analysis of TNseq libraries.
Whole-Cell Compound Uptake Assay
E. coli Omp8 strains harboring plasmids with arabinose-inducible pseudomo-
nal channels were grown overnight in M9G containing ampicillin. Overnight
cultures were diluted 1:50 in fresh M9G and grown shaking for 5 hr at 37, at
which point L-arabinose (Sigma) was added at 0.0125% and cells were
allowed to induce channel expression for 3 hr. Cells were diluted 1:100 into
fresh M9G and 100-ml aliquots were used to inoculate the wells of 96-well
round-bottom plates (Corning 3799) containing test antibiotics, ampicillin (final
concentration 100 mg/ml), and L-arabinose (final concentration 0.0125%). A
tetrazolium salt solution containing WST-8 (Sigma; CCK-8) was used at a final
concentration of 2% to aid in visualization of cell growth.
Metadynamics Simulations of OccD1 and OccD3
All simulations were performed using Desmond (Bowers et al., 2006) and the
Schro¨dinger suite of modeling tools (Schro¨dinger, 2014). X-Ray crystal struc-
tures were used as starting points for simulations on OccD1 and OccD3 (Eren
et al., 2012) (PDB IDs 3SY7 and 3SYB, respectively). Please see Supplemental
Information for a detailed description of the methods employed.
Carbapenem Synthesis
The experimental methods for the synthesis of compounds 7 and 8 can be
found in the Supplemental Information.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
three figures, and four tables and can be found with this article online at
http://dx.doi.org/10.1016/j.chembiol.2015.03.018.
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